INVO Bioscience enters $265k cash advance; senior lender imposes equity raise condition to avoid interest hike

INVO Fertility, Inc.

Cedar Advance LLC purchased $384,250 of future sales for gross $265,000; net proceeds $251,750.
Weekly payments of $9,606 until purchase price repaid; proceeds for working capital.
Decathlon amendment: if INVO fails to raise $1M net equity by Nov 30, 2024, minimum interest multiples rise 0.15x.
Cedar Advance subordinated to Decathlon's senior lien via separate agreement.
Transaction authorized by Decathlon under restated first amendment to revenue loan agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.